PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy have?
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy has 2,356 citations in the OpenAlex counts ScholarIQ stores.
When was PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy published?
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy has 2015 year in the ScholarIQ index.
What is the open-access status of PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy?
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy has closed oa status in the ScholarIQ index.
What is the DOI of PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy?
The DOI for PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy is on the source record.
What is the PMID of PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy?
The PMID for PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy is on the source record.
What is the OpenAlex record for PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy?
The OpenAlex for PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy is on the source record.